Clinical trial
Immune Reconstitution in naïve HIV Patients With CD4 <100 Cells/mL When Treated…
NCT00386659 · Hospital Clinic of Barcelona, Other · Terminated
Key facts
| NCT number | NCT00386659 |
|---|---|
| Title | Immune Reconstitution in naïve HIV Patients With CD4 <100 Cells/mL When Treated With Lopinavir or Efavirenz. |
| Official title | A Randomized, Pilot Study on the Antiviral Activity and Immunological Effects of Lopinavir/Ritonavir vs. Efavirenz in Treatment-naïve HIV-Infected Patients With CD4 Cell Counts Below 100 Cells/mm3 |
| Lead sponsor | Hospital Clinic of Barcelona, Other |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infection |
| Intervention type | Drug |
| Interventions | tenofovir + abacavir + lopinavir/ritonavir, tenofovir + abacavir + efavirenz |
| Enrollment | 60 |
| First posted | Oct 11, 2006 |
| Last update posted | Oct 11, 2006 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: